Asbestos-Related Disease: Multimedia

References

1. Pierce JS, McKinley MA, Paustenbach DJ, et al. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(3):191-214. [Medline].

2. Aguilar-Madrid G, Juárez-Pérez CA, Markowitz S, et al. Globalization and the transfer of hazardous industry: asbestos in Mexico, 1979-2000. Int J Occup Environ Health. Jul-Sep 2003;9(3):272-9. [Medline].

3. Morse T, Grey M, Storey E. Occupational disease in Connecticut, 2000. Conn Med. Dec 2002;66(12):723-30. [Medline].

4. Ribak J, Ribak G. Human health effects associated with the commercial use of grunerite asbestos (amosite): Paterson, NJ; Tyler, TX; Uxbridge, UK. Regul Toxicol Pharmacol. Oct 11 2007 [Epub ahead of print];[Medline].

5. Bolton C, Richards A, Ebden P. Asbestos-related disease. Hosp Med. Mar 2002;63(3):148-51. [Medline].

6. Roggli VL, Vollmer RT. Twenty-five years of fiber analysis: what have we learned?. Hum Pathol. Mar 2008;39(3):307-15. [Medline].

7. al Jarad N. Asbestos-related disease. J R Coll Physicians Lond. Nov-Dec 1999;33(6):532-6. [Medline].

8. Attanoos RL, Gibbs AR. ''Pseudomesotheliomatous'' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology. Nov 2003;43(5):444-52. [Medline].

9. Bard M, Debrosse D, Caliandro R. [Current insights in malignant pleural mesothelioma]. Bull Cancer. Jan 2002;89(1):67-74. [Medline].

10. Girling DJ, Muers MF, Qian W. Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council. Semin Oncol. Feb 2002;29(1):97-101. [Medline].

11. Puntoni R, Filiberti R, Cerrano PG. Implementation of a molecular epidemiology approach to human pleural malignant mesothelioma. Mutat Res. Nov 2003;544(2-3):385-96. [Medline].

12. van Haarst JM, Baas P, Manegold Ch. Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma. Br J Cancer. Feb 1 2002;86(3):342-5. [Medline].

13. Yilmaz UM, Utkaner G, Yalniz E, et al. Computed tomographic findings of environmental asbestos-related malignant pleural mesothelioma. Respirology. Mar 1998;3(1):33-8. [Medline].

14. Guidotti TL. Apportionment in asbestos-related disease for purposes of compensation. Ind Health. Oct 2002;40(4):295-311. [Medline].

15. Dodson RF, Atkinson MA, Levin JL. Asbestos fiber length as related to potential pathogenicity: a critical review. Am J Ind Med. Sep 2003;44(3):291-7. [Medline].

16. Stayner LT, Kuempel E, Gilbert S, et al. An epidemiologic study of the role of chrysotile asbestos fiber dimensions in determining respiratory disease risk in exposed workers. Occup Environ Med. Dec 20 2007 [Epub ahead of print];[Medline].

17. Chapman SJ, Cookson WO, Musk AW. Benign asbestos pleural diseases. Curr Opin Pulm Med. Jul 2003;9(4):266-71. [Medline].

18. Peacock C, Copley SJ, Hansell DM. Asbestos-related benign pleural disease. Clin Radiol. Jun 2000;55(6):422-32. [Medline].

19. Staples CA. Computed tomography in the evaluation of benign asbestos-related disorders. Radiol Clin North Am. Nov 1992;30(6):1191-207. [Medline].

20. Metintas M, Ak G, Parspour S, et al. Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma. Lung Cancer. Feb 25 2008 [Epub ahead of print];[Medline].

21. McLoud TC. Conventional radiography in the diagnosis of asbestos-related disease. Radiol Clin North Am. Nov 1992;30(6):1177-89. [Medline].

22. Aberle DR. High-resolution computed tomography of asbestos-related diseases. Semin Roentgenol. Apr 1991;26(2):118-31. [Medline].

23. Huuskonen O, Kivisaari L, Zitting K. High resolution computed tomography classification of lung fibrosis for patients with asbestos-related disease. Scand J Work Environ Health. 2001;27:106-12. [Medline].

24. Cordasco EM, O''Donnell J, MacIntyre W, et al. Multiplane gallium tomography in assessment of occupational chest diseases. Am J Ind Med. 1990;17(3):285-97. [Medline].

25. Tiitola M, Kivisaari L, Huuskonen MS. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer. Jan 2002;35(1):17-22. [Medline].

26. Tiitola M, Kivisaari L, Zitting A. Computed tomography of asbestos-related pleural abnormalities. Int Arch Occup Environ Health. Apr 2002;75(4):224-8. [Medline].

27. Murray KA, Gamsu G, Webb WR, et al. High-resolution computed tomography sampling for detection of asbestos-related lung disease. Acad Radiol. Feb 1995;2(2):111-5. [Medline].

28. Epstein DM, Miller WT, Bresnitz EA, et al. Application of ILO classification to a population without industrial exposure: findings to be differentiated from pneumoconiosis. AJR Am J Roentgenol. Jan 1984;142(1):53-8. [Medline]. [Full Text].

29. Majurin ML, Varpula M, Kurki T, et al. High-resolution CT of the lung in asbestos-exposed subjects. Comparison of low-dose and high-dose HRCT. Acta Radiol. Sep 1994;35(5):473-7. [Medline].

30. Roach HD, Davies GJ, Attanoos R. Asbestos: when the dust settles--an imaging review of asbestos-related disease. Radiographics. Oct 2002;22 Spec No:S167-84. [Medline]. [Full Text].

31. Gamsu G. Computed tomography and high-resolution computed tomography of pneumoconioses. J Occup Med. Jul 1991;33(7):794-6. [Medline].

32. Jarad NA, Underwood SR, Rudd RM. Asbestos-related pericardial thickening detected by magnetic resonance imaging. Respir Med. May 1993;87(4):309-12. [Medline].

33. Lerman Y, Ribak J, Selikoff IJ. Hazards of lung biopsy in asbestos workers. Br J Ind Med. Mar 1986;43(3):165-9. [Medline].

34. Tukiainen P, Taskinen E, Korhola O, et al. TruCutR needle biopsy in asbestosis and silicosis: correlation of histological changes with radiographic changes and pulmonary function in 41 patients. Br J Ind Med. Nov 1978;35(4):292-304. [Medline].

35. Leiman G. Asbestos bodies in fine needle aspirates of lung masses. Markers of underlying pathology. Acta Cytol. Mar-Apr 1991;35(2):171-4. [Medline].

36. Miller WT Jr, Gupta PK, Grippi MA, et al. Rounded atelectasis: diagnosis by fine-needle aspiration cytology. Diagn Cytopathol. 1992;8(6):617-20. [Medline].

37. Roggli VL, Johnston WW, Kaminsky DB. Asbestos bodies in fine needle aspirates of the lung. Acta Cytol. Jul-Aug 1984;28(4):493-8. [Medline].

38. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg. Aug 2002;22(2):298-305. [Medline].

39. Boutin C, Cargnino P, Viallat J. [Thoracoscopy in chronic pleural effusion (author's transl)]. Poumon Coeur. 1979;35(1):23-9. [Medline].

40. Dujic Z, Tocilj J, Saric M. Early detection of interstitial lung disease in asbestos exposed non- smoking workers by mid-expiratory flow rate and high resolution computed tomography. Br J Ind Med. Oct 1991;48(10):663-4. [Medline].

41. Hu H, Beckett L, Kelsey K, Christiani D. The left-sided predominance of asbestos-related pleural disease. Am Rev Respir Dis. Oct 1993;148(4 Pt 1):981-4. [Medline].

42. Neri S, Boraschi P, Antonelli A, et al. Pulmonary function, smoking habits, and high resolution computed tomography (HRCT) early abnormalities of lung and pleural fibrosis in shipyard workers exposed to asbestos. Am J Ind Med. Nov 1996;30(5):588-95. [Medline].

43. Ohnishi K. [Interferon-alpha therapy in chronic myelogenous leukemia]. Rinsho Ketsueki. Apr 2000;41(4):275-9. [Medline].

44. Turton CW. Pleural effusions. Br J Hosp Med. Mar 1980;23(3):239-40, 244, 246-7 passim. [Medline].

45. Whitman GJ, Niklason LT, Pandit M. Dual-energy digital subtraction chest radiography: technical considerations. Curr Probl Diagn Radiol. Mar-Apr 2002;31(2):48-62. [Medline].

Further Reading

Keywords

asbestos, amphiboles, crocidolite, blue asbestos, amosite, brown asbestos, actinolite, anthophyllite, tremolite, chrysotile, white asbestos, serpentine asbestos, lung disease, respiratory disease, benign pleural effusion, pleural plaques, diffuse pleural thickening, round atelectasis, asbestosis, mesothelioma, lung cancer, diffuse lung fibrosis, lung fibrosis, pulmonary pseudotumor, Blesovsky syndrome

Contributor Information and Disclosures

Author

Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP, Chairman of Medical Imaging, Professor of Radiology, NGHA, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia
Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP is a member of the following medical societies: American Institute of Ultrasound in Medicine, Radiological Society of North America, Royal College of Physicians, Royal College of Physicians and Surgeons of the United States, Royal College of Radiologists, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.

Coauthor(s)

Klaus L Irion, MD, PhD, Consulting Staff, The Cardiothoracic Centre Liverpool NHS Trust, The Royal Liverpool University Hospital, UK
Klaus L Irion, MD, PhD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Sarah Al Ghanem, MBBS, Consulting Staff, Department of Medical Imaging, King Fahad National Guard Hospital, Saudi Arabia
Disclosure: Nothing to disclose.

Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute
Sumaira MacDonald, MBChB, PhD, MRCP, FRCR is a member of the following medical societies: British Medical Association, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.

Carolyn M Allen, MB, BCh, MRCP, FRCR, CCST, Consultant Radiologist, Department of Clinical Radiology, North Manchester General Hospital, UK
Carolyn M Allen, MB, BCh, MRCP, FRCR, CCST is a member of the following medical societies: Society of Thoracic Radiology
Disclosure: Nothing to disclose.

Medical Editor

Judith K Amorosa, MD, FACR, Clinical Professor and Program Director, Department of Radiology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School; Consulting Staff, Department of Radiology, Robert Wood Johnson University Hospital
Judith K Amorosa, MD, FACR is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America, and Society of Thoracic Radiology
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Eric J Stern, MD, Professor of Radiology, Adjunct Professor of Medicine, Adjunct Professor of Medical Education and Biomedical Informatics, University of Washington School of Medicine; Director of Thoracic Imaging, Harborview Medical Center; Associate Medical Staff, Seattle Cancer Care Alliance
Eric J Stern, MD is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, European Society of Radiology, Radiological Society of North America, and Society of Thoracic Radiology
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Barry H Gross, MD, Professor, Department of Radiology, University of Michigan Medical School; Professor, University of Michigan Cancer Center
Barry H Gross, MD is a member of the following medical societies: American College of Chest Physicians, American College of Radiology, American Roentgen Ray Society, Association of University Radiologists, Michigan State Medical Society, Physicians for Social Responsibility, Radiological Society of North America, and Society of Thoracic Radiology
Disclosure: Nothing to disclose.